MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.17703

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2023

Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea.

Yau Yuk Kam, Su Qi, Xu Zhilu, Tang Whitney, Ching Jessica Y L, Mak Joyce Wing Yan, Cheung Chun Pan, Fung Matthew, Ip Margaret, Chan Paul Kay Sheung, Wu Justin Che Yuen, Chan Francis Ka Leung, Ng Siew C

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Faecal microbiota transplantation (FMT) has been shown to improve symptoms in a proportion of patients with irritable bowel syndrome (IBS).

AIM: We performed a randomised trial to assess the efficacy of FMT in patients with IBS.

METHODS

We randomised 56 patients with diarrhoea-predominant IBS 1:1 to FMT or placebo via the duodenal route at baseline and week 4. The primary outcome was > 50 points decrease in IBS severity scoring system (IBS-SSS) score at week 12. Secondary outcomes were improvement in bloating and change in gut microbiota at week 12. After 12-week follow-up, those in the placebo group were assigned to receive open-label FMT.

RESULTS

At week 12, 57.1% in the FMT group and 46.4% in the placebo group achieved the primary endpoint (p = 0.42). More patients receiving FMT than placebo had improvement in bloating (72% vs 30%; p = 0.005). In an open-label extension, 65.2% and 82.4% of patients achieved, respectively, the primary endpoint and improvement in bloating. Faecal microbiome of patients in the FMT group showed a reduction in bacteria like Ruminococcus gnavus and enrichment of bacteria such as Lawsonibacter at week 12, while no change in the placebo group. Functional analyses showed that the hydrogen sulphide-producing pathway decreased in patients who had FMT (p < 0.05) accompanied by a reduction in contributing bacteria. There were no serious adverse events related to FMT.

CONCLUSION

FMT performed twice at an interval of four weeks did not significantly reduce IBS-SSS score. However, more patients had improvement in abdominal bloating, which was associated with a reduction in hydrogen sulphide-producing bacteria. (ClinicalTrials.gov NCT03125564).

Для цитирования: Yau Yuk Kam, Su Qi, Xu Zhilu, Tang Whitney, Ching Jessica Y L, Mak Joyce Wing Yan, Cheung Chun Pan, Fung Matthew, Ip Margaret, Chan Paul Kay Sheung, Wu Justin Che Yuen, Chan Francis Ka Leung, Ng Siew C. Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea.. Alimentary pharmacology & therapeutics. 2023. DOI: 10.1111/apt.17703.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.